Fröhlich, Hanna
Bossmeyer, Anna
Kazmi, Syed
Goode, Kevin M.
Agewall, Stefan
Atar, Dan
Grundtvig, Morten
Frey, Norbert
Cleland, John G. F.
Frankenstein, Lutz http://orcid.org/0000-0001-7216-1004
Clark, Andrew L.
Täger, Tobias
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 21 September 2021
Accepted: 13 September 2022
First Online: 22 August 2023
Declarations
:
: Prof. Atar reports personal fees from Astra-Zeneca, personal fees from Boehringer-Ingelheim, personal fees from Novartis and personal fees from MSD (outside the submitted work). Prof. Cleland reports personal fees from Abbott, personal fees from Amgen, grants and personal fees from Bayer, grants and personal fees from Bristol Myers Squibb, personal fees from Novartis, personal fees from Medtronic, personal fees from Idorsia, grants and personal fees from Vifor, grants and personal fees from Pharmacosmos, grants and personal fees from Cytokinetics, personal fees from Servier, non-financial support from Boehringer-Ingelheim, personal fees from Astra-Zeneca, personal fees from Innolife, personal fees from Torrent, grants and personal fees from Johnson & Johnson, grants and personal fees from Myokardia, personal fees from Respicardia, grants and personal fees from Stealth Biopharmaceuticals, and grants and personal fees from Viscardia (outside the submitted work). Prof. Frankenstein reports personal fees from Astra-Zeneca, grants and personal fees from Bayer, personal fees from Boehringer (outside the submitted work). Prof. Frey reports personal fees from Boehringer and personal fees from AstraZeneca (outside the submitted work).